CAFC Updates

The University of Texas (UT) and TissueGen sued Boston Scientific for infringement of U.S. Patent Nos. 6,596,296 and 7,033,603, which are directed to...

Allergan sued Appellants Sandoz and Alcon, asserting that Sandoz’s Abbreviated New Drug Application (“ANDA”) for a generic version of Allergan’s ophthalmic drug Combigan®...

In an inter partes review, the Patent Trial and Appeal Board ruled claims 10 and 11 of Arthrex’s U.S. Patent No. 8,821,541 (relating to a...

Techtronic appeals from the opinion and order of the district court denying its motion for judgment as a matter of law (JMOL) that...

Anza filed this action alleging that Mushkin had infringed claims of Anza’s U.S. Patent No. 7,124,927 relating to tools and techniques (“wire bonding”...

MyMail appeals the District Court’s decision granting ooVoo’s motions for judgment on the pleadings in MyMail’s suit for infringement of U.S. Patent Nos....

Nalpropion holds a New Drug Application for and markets Contrave® for weight management in overweight or obese adults and asserted three patents against...

Sanofi appeals from the District Court’s judgment holding, after a bench trial, certain claims U.S. Patent 8,927,592 (relating to the compound cabazitaxel and...

The Toro Company sought inter partes review of claims of U.S. Patent No. 8,011,458 relating to steering and driving system for zero...

Iridescent sued AT&T and Ericsson for infringement of U.S. Patent No. 8,036,119 relating to systems and methods of network communication that provide guaranteed...